Figure 3.

Disappearance of aromatase expression in the eutopic endometrium of an endometriosis patient with the use of drospirenone + ethinylestradiol + resveratrol for 2 months (right).

Note: Aromatase expression was detected in the endometrium of this patient prior to treatment.